"We are excited to have received the German regulatory health authority's approval to take ANAVEX 2-73 into the clinic. This marks a key milestone for our company," said Dr. Cameron Durrant, Executive Chairman of Anavex.
"We are very pleased to have received this approval, which supports the data generated thus far on ANAVEX 2-73. The CTA package submitted was of the quality required to p#### this stringent regulatory review by the Germany Health Authority, BfArM," said Dr. Angelos Stergiou, Anavex's Vice President, Clinical Development & Medical Affairs.
See this Amp at http://bit.ly/fdN5df
No comments:
Post a Comment